Hart CA - Search Results

1

Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.

Tawadros T, Brown MD, Hart CA, Clarke NW. Tawadros T, et al. Among authors: hart ca. Br J Cancer. 2012 Nov 6;107(10):1737-44. doi: 10.1038/bjc.2012.457. Epub 2012 Oct 4. Br J Cancer. 2012. PMID: 23037715 Free PMC article.

2

Molecular mechanisms of metastasis in prostate cancer.

Clarke NW, Hart CA, Brown MD. Clarke NW, et al. Among authors: hart ca. Asian J Androl. 2009 Jan;11(1):57-67. doi: 10.1038/aja.2008.29. Epub 2008 Dec 1. Asian J Androl. 2009. PMID: 19050684 Free PMC article. Review.

3

Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer.

Sachdeva A, Hart CA, Kim K, Tawadros T, Oliveira P, Shanks J, Brown M, Clarke N. Sachdeva A, et al. Among authors: hart ca. Br J Cancer. 2022 Oct;127(7):1254-1262. doi: 10.1038/s41416-022-01914-3. Epub 2022 Jul 22. Br J Cancer. 2022. PMID: 35869144 Free PMC article.

4

Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.

Montague R, Hart CA, George NJ, Ramani VA, Brown MD, Clarke NW. Montague R, et al. Among authors: hart ca. Eur Urol. 2004 Sep;46(3):389-401; discussion 401-2. doi: 10.1016/j.eururo.2004.04.022. Eur Urol. 2004. PMID: 15306113

5

Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies.

Hart CA, Scott LJ, Bagley S, Bryden AA, Clarke NW, Lang SH. Hart CA, et al. Br J Cancer. 2002 Apr 8;86(7):1136-42. doi: 10.1038/sj.bjc.6600207. Br J Cancer. 2002. PMID: 11953862 Free PMC article.

6

Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process.

Hart CA, Brown M, Bagley S, Sharrard M, Clarke NW. Hart CA, et al. Br J Cancer. 2005 Feb 14;92(3):503-12. doi: 10.1038/sj.bjc.6602325. Br J Cancer. 2005. PMID: 15668715 Free PMC article.

7

Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs.

Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW. Brown MD, et al. Among authors: hart ca. Br J Cancer. 2006 Mar 27;94(6):842-53. doi: 10.1038/sj.bjc.6603030. Br J Cancer. 2006. PMID: 16523199 Free PMC article.

8

Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer.

Brown M, Roulson JA, Hart CA, Tawadros T, Clarke NW. Brown M, et al. Among authors: hart ca. Br J Cancer. 2014 Apr 15;110(8):2099-108. doi: 10.1038/bjc.2014.99. Epub 2014 Mar 4. Br J Cancer. 2014. PMID: 24595005 Free PMC article.

9

Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer.

Brown MD, Hart C, Gazi E, Gardner P, Lockyer N, Clarke N. Brown MD, et al. Br J Cancer. 2010 Jan 19;102(2):403-13. doi: 10.1038/sj.bjc.6605481. Epub 2009 Dec 8. Br J Cancer. 2010. PMID: 19997104 Free PMC article.

10

The differential effects of statins on the metastatic behaviour of prostate cancer.

Brown M, Hart C, Tawadros T, Ramani V, Sangar V, Lau M, Clarke N. Brown M, et al. Br J Cancer. 2012 May 8;106(10):1689-96. doi: 10.1038/bjc.2012.138. Epub 2012 Apr 24. Br J Cancer. 2012. PMID: 22531631 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

684 results

Search Page

Filters